Effect of sorafenib combined with cytostatic agents on hepatoblastoma cell lines and xenografts

BACKGROUND: Sorafenib has recently been shown to reduce tumour growth in hepatoblastoma (HB) xenografts. The effect of a combined administration with cytostatic agents was now investigated. METHODS: Cell viability after treatment with sorafenib and different cytostatic agents was evaluated in two HB...

Descripción completa

Detalles Bibliográficos
Autores principales: Eicher, C, Dewerth, A, Thomale, J, Ellerkamp, V, Hildenbrand, S, Warmann, S W, Fuchs, J, Armeanu-Ebinger, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566826/
https://www.ncbi.nlm.nih.gov/pubmed/23257893
http://dx.doi.org/10.1038/bjc.2012.539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566826/
https://www.ncbi.nlm.nih.gov/pubmed/23257893
http://dx.doi.org/10.1038/bjc.2012.539

Ejemplares similares